EVO Evotec
- 5.230
- -2.420-31.63%
- 5.180
- -0.050-0.96%
Evotec News
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kineta (KA), Gilead Sciences (GILD) and Evotec AG (EVO)
Analysts Conflicted on These Healthcare Names: Evotec AG (EVO), Collegium Pharmaceutical (COLL) and Fortrea Holdings Inc. (FTRE)
Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Lyra Therapeutics (LYRA) and Alpine Immune Sciences (ALPN)
HC Wainwright & Co. Maintains Buy on Evotec, Raises Price Target to $14
Evotec Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $12 Price Target
Evotec Analyst Ratings
Morgan Stanley Upgrades Evotec to Overweight, Raises Price Target to $16
BofA Downgrades Evotec to Neutral Over Cyber-attack Concerns
B of A Securities Downgrades Evotec to Neutral, Announces $13 Price Target
Morgan Stanley Upgrades Evotec to Equalweight From Underweight, Raise Price Target to $12 From $11
HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $12 Price Target
Analysts Offer Insights on Healthcare Companies: Cardiff Oncology (CRDF), Evotec AG (EVO) and Harpoon Therapeutics (HARP)
Analysts Conflicted on These Healthcare Names: Can-Fite BioPharma (CANF), CareDx (CDNA) and Evotec AG (EVO)
Evotec Analyst Ratings
Evotec Analyst Ratings
Deutsche Bank Downgrades Evotec SE to Hold From Buy After Weaker-Than-Expected Q3 Results, Cuts Price Target to EUR21 From EUR26
Evotec Analyst Ratings
Evotec analyst ratings
Morgan Stanley Downgrades Evotec to Underweight, Announces $16 Price Target
Analysis
Price Target
No Data
